HMGN1 and glioblastoma: The findings revealed that stromal and immune scores showed a significant and negative link with the HMGN1 expression levels in eight types of cancers like BRCA, BLCA, COAD, CESC, GBM, LUAD, OV, and STAD (p< 0.05) (Fig. 7).